Now showing items 1-1 of 1

    • Thumbnail

      Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation 

      Barbier Torres, Lucía; Fortner, Karen A.; Iruzubieta, Paula; Delgado, Teresa C.; Giddings, Emily; Chen, Youdinghuan; Champagne, Devin; Fernández Ramos, David; Mestre, Daniela; Gómez Santos, Beatriz; Varela Rey, Marta; Gutiérrez de Juan, Virginia; Fernández Tussy, Pablo; Zubiete Franco, Imanol; García Monzón, Carmelo; González Rodríguez, Águeda; Oza, Dhaval; Valença Pereira, Felipe; Fang, Qian; Crespo, Javier; Aspichueta Celaá, Patricia; Tremblay, Frederic; Christensen, Brock C.; Anguita Castillo, Juan de Dios; Martínez Chantar, María Luz ORCID; Rincón, Mercedes (Nature, 2020-07-03)
      Nonalcoholic fatty liver disease (NAFLD) is considered the next major health epidemic with an estimated 25% worldwide prevalence. No drugs have yet been approved and NAFLD remains a major unmet need. Here, we identify MCJ ...